Gelesis Leadership

Mr. Zohar is the Founder and Chief Executive Officer of Gelesis Inc., a Boston-based medical technology company developing innovative technologies to treat obesity and related co-morbidities. A seasoned entrepreneur, Mr. Zohar has over 25 years experience in the launch and development of industry innovating companies. Prior to founding Gelesis, Mr. Zohar was a Co-Founder and Partner of PureTech Ventures, a Boston-based venture group focused on the translation of academic breakthroughs into commercially viable companies. In his role at PureTech he co-founded and ran several innovative companies, including Gelesis. Prior to co-founding PureTech, Mr. Zohar co-founded and was the CEO of Zeta Ltd, a market leader in the Israeli consumer/edible goods market.

Tracey Coyle Grazio is a Conference Administrator at MedExecWomen; Executive Assistant/Office Manager to the CEO/Founder, COCO, CMO, CSO at Gelesis; and Finance Committee Member at MERRIMAC, TOWN OF and is based in Boston, Massachusetts. She has worked as Project Manager (Contractor) at Bink, Inc.; Senior Executive Assistant to the CIO at Columbia Threadneedle Investments; and Club Administrator at NEW ENGLAND WOMEN IN SCIENCE EXECUTIVES CLUB INC. Tracey attended Northeastern University between 1993 and 1996, Aimr, and STATE STREET CORP.

I am a senior healthcare executive, and for over 25 years I have served in C-suite roles within a diverse group of innovative healthcare companies. My passion is building high performance teams while leveraging my business, leadership, and clinical skills to create services, and intellectual property that improve the health of large populations - at scale - while contributing significant value to the business.

My recent role at Walgreens Boots Alliance provided me with a global opportunity to leverage a unique platform to impact the 6 million customers who visit a Walgreens store each day, as well as the 2 million customers who interact with Walgreens digitally.

In my previous roles working for health plans, population health companies, a healthcare market research firm, and a speciality lab, I served as the most senior clinical leader and spokesperson interacting with providers, integrated delivery systems, payors, legislators and CMS. Through my ability to build high performing services and teams, I positively impacted sales, market share, and corporate profitability for each company.

Accomplished Pharmaceutical Leader with extensive experience in all aspects of Medical Affairs including Medical Education, Advocacy, and External Collaborative Innovation. Scientific content expertise in Pharmacology, Obesity, Diabetes, Cardiometabolic, and Epidemiology. Created and directed a comprehensive integrated approach for all aspects of external customer strategic activities for a leading metabolic biomedical company. Led strategic planning, content, procedures, and execution of advocacy and advisory board activities, increasing awareness and appropriate adoption of first-in-class therapeutics for diabetes. Identified and successfully led two multi-million dollar research collaborative initiatives with a nonprofit patient advocacy organization (Juvenile Diabetes Research Foundation). Responsible for protocol development, conduct, budget management, and publication plans for both initiatives. Worked closely with Regional, National and International Obesity Thoughts Leaders as Expert Consultant for the Texas Department of Health, Obesity Task Force, and the National Heart Lung and Blood Institute Obesity Education Initiative Expert Panel. Authored a book on Evidenced-based Pharmacotherapy, published more than 40 peer-reviewed scientific articles and inventor on one patent application. Recipient of 3 Medical Achievement Awards at Amylin and one at Bristol Myers Squibb. Mentored and developed personnel to excel in all aspects of Medical Affairs roles.

Mr. Zohar is the Founder and Chief Executive Officer of Gelesis Inc., a Boston-based medical technology company developing innovative technologies to treat obesity and related co-morbidities. A seasoned entrepreneur, Mr. Zohar has over 25 years experience in the launch and development of industry innovating companies. Prior to founding Gelesis, Mr. Zohar was a Co-Founder and Partner of PureTech Ventures, a Boston-based venture group focused on the translation of academic breakthroughs into commercially viable companies. In his role at PureTech he co-founded and ran several innovative companies, including Gelesis. Prior to co-founding PureTech, Mr. Zohar co-founded and was the CEO of Zeta Ltd, a market leader in the Israeli consumer/edible goods market.

Tracey Coyle Grazio is a Conference Administrator at MedExecWomen; Executive Assistant/Office Manager to the CEO/Founder, COCO, CMO, CSO at Gelesis; and Finance Committee Member at MERRIMAC, TOWN OF and is based in Boston, Massachusetts. She has worked as Project Manager (Contractor) at Bink, Inc.; Senior Executive Assistant to the CIO at Columbia Threadneedle Investments; and Club Administrator at NEW ENGLAND WOMEN IN SCIENCE EXECUTIVES CLUB INC. Tracey attended Northeastern University between 1993 and 1996, Aimr, and STATE STREET CORP.

Mr. Zohar is the Founder and Chief Executive Officer of Gelesis Inc., a Boston-based medical technology company developing innovative technologies to treat obesity and related co-morbidities. A seasoned entrepreneur, Mr. Zohar has over 25 years experience in the launch and development of industry innovating companies. Prior to founding Gelesis, Mr. Zohar was a Co-Founder and Partner of PureTech Ventures, a Boston-based venture group focused on the translation of academic breakthroughs into commercially viable companies. In his role at PureTech he co-founded and ran several innovative companies, including Gelesis. Prior to co-founding PureTech, Mr. Zohar co-founded and was the CEO of Zeta Ltd, a market leader in the Israeli consumer/edible goods market.